High-affinity synthetic nanobodies (sybodies) against TGP have been generated using ribosome and phage display 59 , enabling purification of a membrane protein to comparable purity (~90%) with that from immobilized metal affinity chromatography
A small number of GHR antagonists have been used in an oncology settings in preclinical studies and the growth-inhibiting effects have been reported in colon, breast, and meningioma tumor xenografts, which suggested that GHR antagonism as a monotherapy is efficient in some tumor types (Friend, 2001
doi: 10.1007/s12028-019-00829-x
* Listen to Your Body: Pay attention to pain signals and rest when needed
J Clin Oncol 19:32443254 Strop P, Liu S-H, Dorywalska M, Delaria K, Dushin RG, Tran T-T, Ho W-H, Farias S, Casas MG, Abdiche Y et al (2013) Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates